NCT05984511: TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT |
|
|
| Not yet recruiting | 3 | 234 | NA | I-125 Seeds Brachytherapy in PVTT, Iodine-125 Seeds Implantation, Transcatheter arterial chemoembolization, TACE, Atezolizumab plus Bevacizumab, atezolizumab-bevacizumab; Atez/Bev treatment | Third Affiliated Hospital, Sun Yat-Sen University, Sun Yat-sen University, Fifth Affiliated Hospital, Sun Yat-Sen University, Second Affiliated Hospital of Guangzhou Medical University, Maoming People's Hospital, Shandong Provincial Third Hospital | Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus | 08/28 | 08/29 | | |
